Inventor

Gary L. Bolton

Inventor
Ann Arbor, MI, US

Overview

22→
Patents
1993–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds24%
A61KPreparations for medical, dental or toiletry purposes19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07CAcyclic or carbocyclic compounds11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C07JSteroids4%
C07KPeptides4%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry3%
C07BGeneral methods of organic chemistry3%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds3%
PatentTitleYear
11,059,792Imidazolyl tricyclic enones as antioxidant inflammation modulators20219,884,809'Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators'20189,796,668'Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use'20179,464,082'Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators'20169,233,998'Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use'20169,174,941'Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators'20158,513,436'Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators'20138,258,329'Dehydroandrosterone analogs including an anti-inflammatory pharmacore and methods of use'20127,179,918'HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis'20076,953,858'HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis'20056,506,701'Rapid purification by polymer supported quench'20036,306,959'Rapid purification by polymer supported quench'20016,133,270'Isothiazolones and pharmaceutical formulations'20006,001,863'Isothiazolones'19995,919,780'Tricyclic inhibitors of protein farnesyltransferase'19995,889,034'Isothiazolones'19995,830,868'Substituted DI- and tripeptide inhibitors of protein: farnesyl transferase'19985,763,577'Substituted tetra- and pentapeptide inhibitors of protein: farnesyl transferase'19985,733,921'Isothiazolone compounds'19985,620,997'Isothiazolones'19975,571,792'Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase'19965,208,224'Phosphorus containing compounds as antihypercholesterolemic and antiatherosclerotic agents'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2003Patents assigned to WARNER LAMBERT CO (12)· patent assignee history
1993–2021Based in Ann Arbor, MI, US· patent location history
2012–2021Patents assigned to REATA PHARMACEUTICALS INC (8)· patent assignee history
2012–2016Patents assigned to ANDERSON ERIC (3)· patent assignee history
2012–2016Patents assigned to BOLTON GARY L (3)· patent assignee history
2012–2016Patents assigned to JIANG XIN (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
WARNER LAMBERT CO121993–2003
REATA PHARMACEUTICALS INC82012–2021
ANDERSON ERIC32012–2016
BOLTON GARY Lself32012–2016
JIANG XIN32012–2016
Locations
LocationPatentsSpan
Ann Arbor, MI, US221993–2021